A Novel Phenanthridionone Based Scaffold As a Potential Inhibitor of the BRD2 Bromodomain: Crystal Structure of the Complex.
Bromodomain containing proteins recognize the level of histone acetylation and regulate epigenetically controlled processes like gene transcription and chromatin modification. The BET (bromodomain and extra-terminal) family proteins, which are transcriptional co-regulators, have been implicated in t...
Main Authors: | Shailesh Tripathi, Shruti Mathur, Prashant Deshmukh, Ramu Manjula, Balasundaram Padmanabhan |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0156344 |
Similar Items
-
Preparation data of the bromodomains BRD3(1), BRD3(2), BRD4(1), and BRPF1B and crystallization of BRD4(1)-inhibitor complexes
by: Martin Hügle, et al.
Published: (2016-06-01) -
BRD3 and BRD4 BET Bromodomain Proteins Differentially Regulate Skeletal Myogenesis
by: Thomas C. Roberts, et al.
Published: (2017-07-01) -
Bromodomain-Containing Protein BRD4 Is Hyperphosphorylated in Mitosis
by: Ranran Wang, et al.
Published: (2020-06-01) -
Synthesis and Structure–Activity Relationships of Aristoyagonine Derivatives as Brd4 Bromodomain Inhibitors with X-ray Co-Crystal Research
by: Minjin Yoo, et al.
Published: (2021-03-01) -
BET Bromodomain Proteins Brd2, Brd3 and Brd4 Selectively Regulate Metabolic Pathways in the Pancreatic β-Cell.
by: Jude T Deeney, et al.
Published: (2016-01-01)